Koers Chengdu Kanghua Biological Products Co., Ltd.
Aandelen
300841
CNE100003Y57
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
60,8 CNY | +2,01% | +9,06% | -21,59% |
Omzet 2024 * | 1,81 mld. 250 mln. 233 mln. | Omzet 2025 * | 2,1 mld. 290 mln. 271 mln. | Marktkapitalisatie | 8,13 mld. 1,12 mld. 1,05 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 710 mln. 97,99 mln. 91,64 mln. | Nettowinst (verlies) 2025 * | 815 mln. 112 mln. 105 mln. | EV/omzet 2024 * | 4,5 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 3,88 x |
K/w-verhouding 2024 * |
11,5
x | K/w-verhouding 2025 * |
10,1
x | Werknemers | 672 |
Dividendrendement 2024 * |
2,32% | Dividendrendement 2025 * |
2,65% | Vrij verhandelbaar | 63,46% |
1 dag | +2,01% | ||
1 week | +9,06% | ||
Lopende maand | +9,51% | ||
1 maand | +7,23% | ||
3 maanden | +0,53% | ||
6 maanden | -6,00% | ||
Lopend jaar | -21,59% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Qing Han Wang
CEO | Chief Executive Officer | 50 | 01-05-17 |
Wen Nian Wu
DFI | Director of Finance/CFO | 41 | 01-06-10 |
Wen Li Hou
BRD | Director/Board Member | 41 | 01-05-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Xiao Bo Fang
BRD | Director/Board Member | 50 | 01-03-20 |
Zhen Tao Wang
CHM | Chairman | 58 | - |
Xiong Ping Yu
BRD | Director/Board Member | 48 | 01-05-17 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.15% | 12 M€ | -16,71% | - | |
0.00% | 34 M€ | +2,14% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 60,8 | +2,01% | 2 052 862 |
25-04-24 | 59,6 | -0,13% | 2 292 500 |
24-04-24 | 59,68 | +4,72% | 3 233 532 |
23-04-24 | 56,99 | -1,74% | 2 059 028 |
22-04-24 | 58 | +4,04% | 2 044 265 |
slotkoers Shenzhen S.E., 26 april 2024
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-21,59% | 1,1 mld. | |
-4,66% | 87,53 mld. | |
+1,32% | 40,42 mld. | |
-19,27% | 29,48 mld. | |
+57,86% | 25,43 mld. | |
-17,69% | 11,49 mld. | |
-43,00% | 11,3 mld. | |
-9,14% | 11,1 mld. | |
+5,24% | 8,75 mld. | |
-8,42% | 7,99 mld. |